🔧 Filters
Try: author name · keyword phrase · DOI
Original Article
Introduction: Pediatric metabolic screening is governed by a weight-centric dualism that prioritizes obesity while overlooking cardiometabolic risks in undernutrition. While obesity-related dyslipidem
Pediatric ObesityGrowth DisordersDyslipidemiasChild Health Services.
Original Article
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9i) are highly effective lipid-lowering agents that reduce low-density lipoprotein cholesterol (LDL-C) by enhancing LD
PCSK9PCSK9iLDL-CAlirocumabEvolocumabFamilial hypercholesterolaemia
Original Article
Background: Dyslipidemia, characterized by abnormal blood lipid levels, is a major risk factor for cardiovascular disease, contributing to an estimated 4.2 million deaths and disabilities globally. Th
CholesterolDyslipidemiaHDLLDLLipid ProfileTriglycerides
Original Article
Background: Cardiovascular diseases are one of the leading causes of mortality and morbidity worldwide, with being the leading cause of death globally, taking an estimated 17.9 million lives each year
DepressionLifestyleMental healthMyocardial InfarctionSleep quality
Case Report
Background: Cardiovascular complications are rare in tuberculosis. It causes severe morbidity and mortality. There is paucity of data on cor pulmonale as a complication of pulmonary tuberculosis in pe
pulmonary tuberculosiscardiac dysfunctioncor pulmonaleNigeria
Review Article
Atherosclerosis was found in humans who lived thousands years ago. Paleopathologist Marc Armand Ruffer (1859-1917) identified atherosclerotic plaques in the aorta as well as in several large arteries
AtheromaLipoproteinsLDL cholesterolAncient MedicineExperimental atherosclerosisMolecular Biology